OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis
Ina Mexhitaj, Moffat Nyirenda, Rui Li, et al.
Brain (2019) Vol. 142, Iss. 3, pp. 617-632
Open Access | Times Cited: 76
Ina Mexhitaj, Moffat Nyirenda, Rui Li, et al.
Brain (2019) Vol. 142, Iss. 3, pp. 617-632
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
The immunology of multiple sclerosis
Kathrine E. Attfield, Lise T. Jensen, Max Kaufmann, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 734-750
Closed Access | Times Cited: 220
Kathrine E. Attfield, Lise T. Jensen, Max Kaufmann, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 734-750
Closed Access | Times Cited: 220
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances
Amit Bar‐Or, Rui Li
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 470-483
Closed Access | Times Cited: 151
Amit Bar‐Or, Rui Li
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 470-483
Closed Access | Times Cited: 151
MAIT Cell Development and Functions: the Microbial Connection
François Legoux, Marion Salou, Olivier Lantz
Immunity (2020) Vol. 53, Iss. 4, pp. 710-723
Open Access | Times Cited: 145
François Legoux, Marion Salou, Olivier Lantz
Immunity (2020) Vol. 53, Iss. 4, pp. 710-723
Open Access | Times Cited: 145
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
Alexa DeMaio, Shikhar Mehrotra, Kumar Sambamurti, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 98
Alexa DeMaio, Shikhar Mehrotra, Kumar Sambamurti, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 98
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Resolution of inflammation during multiple sclerosis
Florian Ruiz, Solenne Vigne, Caroline Pot
Seminars in Immunopathology (2019) Vol. 41, Iss. 6, pp. 711-726
Open Access | Times Cited: 108
Florian Ruiz, Solenne Vigne, Caroline Pot
Seminars in Immunopathology (2019) Vol. 41, Iss. 6, pp. 711-726
Open Access | Times Cited: 108
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
Jan D. Lünemann, Tobias Ruck, Paolo A. Muraro, et al.
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 56-62
Closed Access | Times Cited: 91
Jan D. Lünemann, Tobias Ruck, Paolo A. Muraro, et al.
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 56-62
Closed Access | Times Cited: 91
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Christina Lückel, Felix S.R. Picard, Hartmann Raifer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 84
Christina Lückel, Felix S.R. Picard, Hartmann Raifer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 84
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial
Kait F. Al, Laura J. Craven, Shaeley Gibbons, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 55
Kait F. Al, Laura J. Craven, Shaeley Gibbons, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 55
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Koji Shinoda, Rui Li, Ayman Rezk, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 35
Koji Shinoda, Rui Li, Ayman Rezk, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 35
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
Chi‐Yan Lee, Koon‐Ho Chan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
Chi‐Yan Lee, Koon‐Ho Chan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
CCR5 and inflammatory storm
Yu‐Ting Lin, Shasha Liu, Yang Sun, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102286-102286
Closed Access | Times Cited: 13
Yu‐Ting Lin, Shasha Liu, Yang Sun, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102286-102286
Closed Access | Times Cited: 13
Improved relapse recovery in paediatric compared to adult multiple sclerosis
Tanuja Chitnis, Greg Aaen, Anita Belman, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2733-2741
Open Access | Times Cited: 62
Tanuja Chitnis, Greg Aaen, Anita Belman, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2733-2741
Open Access | Times Cited: 62
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age
Leah Zuroff, Ayman Rezk, Koji Shinoda, et al.
EBioMedicine (2022) Vol. 82, pp. 104179-104179
Open Access | Times Cited: 32
Leah Zuroff, Ayman Rezk, Koji Shinoda, et al.
EBioMedicine (2022) Vol. 82, pp. 104179-104179
Open Access | Times Cited: 32
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis
Céline Louapre, Michèlle Rosenzwajg, Marianne Golse, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4403-4414
Closed Access | Times Cited: 17
Céline Louapre, Michèlle Rosenzwajg, Marianne Golse, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4403-4414
Closed Access | Times Cited: 17
CD4+CD25+ regulatory T cells ex vivo generated from autologous naïve CD4+ T cells suppress EAE progression
Tingting Yang, Pen-Ju Liu, Q. Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Tingting Yang, Pen-Ju Liu, Q. Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease
Rui Li, Thomas F. Tropea, Laura Rosa Baratta, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 38
Rui Li, Thomas F. Tropea, Laura Rosa Baratta, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 38
Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder
Xue Ma, Chuan Qin, Man Chen, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 34
Xue Ma, Chuan Qin, Man Chen, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 34
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
Alexandra Garcia, Emilie Dugast, Sita Shah, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 14
Alexandra Garcia, Emilie Dugast, Sita Shah, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 14
EarlyMagnetic Resonance Imaging Features of New Paramagnetic Rim Lesions in Multiple Sclerosis
Kelly Clark, Abby R. Manning, Luyun Chen, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 736-744
Open Access | Times Cited: 12
Kelly Clark, Abby R. Manning, Luyun Chen, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 736-744
Open Access | Times Cited: 12
Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System
Esraa Mohsen, Hesham Haffez, Sandra Ahmed, et al.
Molecular Neurobiology (2025)
Open Access
Esraa Mohsen, Hesham Haffez, Sandra Ahmed, et al.
Molecular Neurobiology (2025)
Open Access
Yerba Mate (Ilex paraguariensis) Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Regulatory T Cell Function
Andrés A. Herrada, Francisca Rodríguez-Arriaza, Alexandra Olate‐Briones, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 897-897
Open Access
Andrés A. Herrada, Francisca Rodríguez-Arriaza, Alexandra Olate‐Briones, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 897-897
Open Access
Reconstitution of CXCR3 +CCR6 + Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis
Shu Yang, Tianxiang Zhang, Jia Liu, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access
Shu Yang, Tianxiang Zhang, Jia Liu, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access
